Dr Quentin Fournier
Senior Clinician, Medical Oncology / DVM Dipl. ECVIM-CA (Oncology) MRCVS
RCVS Recognised Specialist in Veterinary Oncology (Small Animals)
EBVS® European Specialist in Small Animal Oncology
Dipl. Oncology Clinical Research (Project Manager)
Quentin qualified from Alfort Veterinary School (Paris, France) in 2014, and completed a rotating internship in the Small Animal Hospital of the Veterinary Campus of Vetagro-sup (Lyon, France) in 2015. He then enrolled in a combined one-year specialised internship and a three-year residency in Small Animal Oncology at the University of Edinburgh, which he completed in 2019. The same year, Quentin became a Diplomate in Small Animal Oncology and started an oncology service at the Veterinary Hospital Fregis (Paris, France). He was also selected for a one year of training in Oncology Clinical Research organised by Paris-Saclay University and the School of Cancer Sciences and was awarded with a Project Manager diploma.
Quentin joined Fitzpatrick Referrals Oncology and Soft Tissue hospital in September 2020 as a Senior Clinician in Medical Oncology. He is particularly interested in the optimisation of chemotherapy administration and lymph node assessment. He is also passionate about developing new therapeutic and diagnostic modalities to help cancer patients, whilst embracing the One Health concept.
He is delighted to join the team and is looking forward to offering cutting-edge cancer management options for small companion animals. He is very happy to discuss the details of any patient with your family veterinary surgeon should this be helpful.
Publications
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study
: P E Paulos, S Boston, O T Skinner, J M Liptak, P M Amsellem, Q Fournier, C J Wood, M Annoni, D Murgia, M L Oblak, B L Dean, S D Baird, N J Kulendra
Contrast‐enhanced ultrasound for sentinel lymph node mapping in the routine staging of canine mast cell tumours: A feasibility study
: Q Fournier, F Thierry, M Longo, A Malbon, P Cazzini, J Bisson, S Woods, T Liuti, S Bavcar
Les acteurs d’une stratégie thérapeutique en cancérologie
: Q Fournier
Stratégie multimodale et évaluation du traitement en cancérologie
: Q Fournier, D Argyle, D Sayag
Impact of pre-chemotherapy neutrophil count on chemotherapy administration and toxicity in dogs with lymphoma treated with CHOP chemotherapy.
: Q Fournier, J C Serra, I Handel, J Lawrence
Investigation of the utility of lymph node fine-needle aspiration cytology for the staging of malignant solid tumors in dogs
: Q Fournier, P Cazzini, C Balber, R Elders
A previously undescribed cutaneous paraneoplastic syndrome in a cat with thymoma
: Q Fournier, S Bavcar, A Philbey, S Smith, K Varjonen
Evaluation of a 0.75 × 10 9 /L absolute neutrophil count cut-off for antimicrobial prophylaxis in canine cancer chemotherapy patients
: J Bisson, Q Fournier, E Johnston, I Handel, S Bavcar
Characterization of Black Pigmenturia in a Cat with Apocrine Gland Cystadenocarcinoma
: Q Fournier, A Höhn, S Deu, E Milne, bel, S Bavcar, L Morrison
Chemotherapy‐induced diarrhoea in dogs and its management with smectite: Results of a monocentric open‐label randomized clinical trial
: Q Fournier, J C Serra, C Williams, S Bavcar
